Year |
Citation |
Score |
2020 |
Balestrieri K, Kew K, McDaniel M, Ramez M, Pittman K, Murray G, Vohra NA, Verbanac KM. Proteomic identification of tumor- and metastasis-associated galectin-1 in claudin-low breast cancer. Biochimica Et Biophysica Acta. General Subjects. 129784. PMID 33166603 DOI: 10.1016/j.bbagen.2020.129784 |
0.333 |
|
2019 |
Zhu Y, Howard GA, Pittman K, Boykin C, Herring LE, Wilkerson EM, Verbanac K, Lu Q. Therapeutic effect of Y-27632 on tumorigenesis and cisplatin-induced peripheral sensory loss through RhoA-NF-kB. Molecular Cancer Research : McR. PMID 31189689 DOI: 10.1158/1541-7786.Mcr-19-0024 |
0.366 |
|
2019 |
Johnson H, Shivalingappa H, Wong J, Muzaffar M, Verbanac K, Vohra N. Abstract P5-11-12: Longitudinal changes in volumetric breast density and fibroglandular volume with endocrine therapy in African American women with estrogen receptor positive breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P5-11-12 |
0.325 |
|
2019 |
Balestrieri K, McDaniel M, Shoopman C, Vohra N, Verbanac K. Abstract 2147: Galectin-1: A marker for claudin-low breast cancer Cancer Research. 79: 2147-2147. DOI: 10.1158/1538-7445.Am2019-2147 |
0.476 |
|
2017 |
Torres E, Richman AR, Schreier AM, Vohra N, Verbanac K. An Evaluation of a Rural Community-Based Breast Education and Navigation Program: Highlights and Lessons Learned. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. PMID 29150748 DOI: 10.1007/S13187-017-1298-0 |
0.338 |
|
2017 |
Balestrieri K, Pittman K, Ramez M, Vohra N, Verbanac K. Abstract 948: Characterization of the microenvironment of murine primary triple negative breast cancer Cancer Research. 77: 948-948. DOI: 10.1158/1538-7445.Am2017-948 |
0.404 |
|
2016 |
Vohra NA, Kachare SD, Vos P, Schroeder BF, Schuth O, Suttle D, Fitzgerald TL, Wong JH, Verbanac KM. The Short-Term Effect of Weight Loss Surgery on Volumetric Breast Density and Fibroglandular Volume. Obesity Surgery. PMID 27783370 DOI: 10.1007/S11695-016-2415-6 |
0.322 |
|
2016 |
Shivalingappa H, Muzaffar M, Verbanac K, Vohra NA. Volumetric breast density, breast cancer subtypes and race. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E12067 |
0.333 |
|
2016 |
Balestrieri K, Pittman HK, Britt M, Ramez M, Vohra N, Verbanac K. Abstract 1469: The inflammatory pre-metastatic niche in reliably metastatic models of triple negative breast cancer Cancer Research. 76: 1469-1469. DOI: 10.1158/1538-7445.Am2016-1469 |
0.511 |
|
2015 |
Lu Z, Kim do H, Fan J, Lu Q, Verbanac K, Ding L, Renegar R, Chen YH. A non-tight junction function of claudin-7-Interaction with integrin signaling in suppressing lung cancer cell proliferation and detachment. Molecular Cancer. 14: 120. PMID 26081244 DOI: 10.1186/S12943-015-0387-0 |
0.405 |
|
2015 |
Muzaffar M, Kachare SD, Fitzgerald TL, Wong JH, Verbanac K, Vohra NA. Abstract P2-13-26: Trend in primary tumor resection and disease specific survival in patients with metastatic breast cancer: A SEER database analysis (1988-2011) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-13-26 |
0.439 |
|
2013 |
Kachare SD, Cayer JM, Carver FM, Englert ZP, Verbanac KM, Zervos EE, Vohra NA. Abstract LB-321: Combination dendritic cell and conventional chemoradiation therapy improves survival for rectal cancer in a murine model. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-321 |
0.437 |
|
2013 |
Meyers JC, Pittman HK, Story H, Imes DM, Howard GA, Verbanac KM. Abstract LB-285: Pro-tumor N2 neutrophils contribute to the pre-metastatic niche. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-285 |
0.498 |
|
2012 |
Weber JJ, Bellin LS, Milbourn DE, Verbanac KM, Wong JH. Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate. Archives of Surgery (Chicago, Ill. : 1960). 147: 834-9. PMID 22987175 DOI: 10.1001/Archsurg.2012.1660 |
0.321 |
|
2010 |
Verbanac KM, Min CJ, Mannie AE, Lu J, O’Brien KF, Rosman M, Tafra L. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases. Annals of Surgical Oncology. 17: 368-377. PMID 20853060 DOI: 10.1245/S10434-010-1262-2 |
0.368 |
|
2010 |
Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, Tafra L, Verbanac KM. American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer. 116: 2090-8. PMID 20198707 DOI: 10.1002/Cncr.25038 |
0.347 |
|
2009 |
Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Journal of the American College of Surgeons. 208: 333-40. PMID 19317993 DOI: 10.1016/J.Jamcollsurg.2008.10.036 |
0.326 |
|
2008 |
Joshi MU, Pittman HK, Haisch CE, Verbanac KM. Real-time PCR to determine transgene copy number and to quantitate the biolocalization of adoptively transferred cells from EGFP-transgenic mice Biotechniques. 45: 247-258. PMID 18778249 DOI: 10.2144/000112913 |
0.606 |
|
2006 |
Gold LP, Cheng Z, Tafra L, Sawyer K, Verbanac K, Rosman M. The risk of breast cancer recurrence in the sentinel lymph node era Journal of Clinical Oncology. 24: 10600-10600. DOI: 10.1200/Jco.2006.24.18_Suppl.10600 |
0.392 |
|
2005 |
Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, Justus Min C, Mannie A, Tafra L, Atkins D, Verbanac KM. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. The Journal of Molecular Diagnostics : Jmd. 7: 327-36. PMID 16049304 DOI: 10.1016/S1525-1578(10)60561-2 |
0.385 |
|
2004 |
Storey BT, Pittman HK, Christian JF, Haisch CE, Verbanac KM. Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases. Clinical & Experimental Metastasis. 21: 265-73. PMID 15387377 DOI: 10.1023/B:CLIN.0000037728.44457.13 |
0.471 |
|
2004 |
Backus J, Laughlin T, Min CJ, Mannie A, Tafra L, Belly R, Atkins D, Verbanac KM. Validation of markers for the intraoperative detection of metastasis in breast sentinel lymph nodes. Journal of Clinical Oncology. 22: 9547-9547. DOI: 10.1200/Jco.2004.22.90140.9547 |
0.367 |
|
2004 |
Verbanac KM, Min J, Mannie AE, Tafra L. Clinical significance of PCR-detected metastases in sentinel nodes of breast cancer patients: An interim report Journal of Clinical Oncology. 22: 9516-9516. DOI: 10.1200/Jco.2004.22.90140.9516 |
0.385 |
|
2001 |
Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. American Journal of Surgery. 182: 312-315. PMID 11720661 DOI: 10.1016/S0002-9610(01)00718-8 |
0.362 |
|
2001 |
Verbanac KM. Molecular detection of breast cancer markers Molecular Diagnosis. 6: 73-77. PMID 11468692 DOI: 10.1007/Bf03262037 |
0.38 |
|
2001 |
Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Annals of Surgery. 233: 51-9. PMID 11141225 DOI: 10.1097/00000658-200101000-00009 |
0.354 |
|
2001 |
Verbanac KM. Commentary: Molecular detection of breast cancer markers Molecular Diagnosis. 6: 73-77. DOI: 10.1054/Modi.2001.24167 |
0.379 |
|
Show low-probability matches. |